You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 262 No. 14, October 13, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Grand Rounds at the National Institutes of Health
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (18)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Emerging Concepts in the Treatment of HIV Infection in Children

Philip A. Pizzo, MD

JAMA. 1989;262(14):1989-1992.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SELECTED CASE

A 16-MONTH-OLD child was considered to have human immunodeficiency virus (HIV) infection at 4 months of age when she developed acute interstitial pneumonia that was documented by open lung biopsy to be caused by Pneumocystis carinii. The patient's mother was known to be HIV seropositive, having presumably acquired the infection from sexual intercourse with the child's father, a known intravenous drug user. The patient's episode with P carinii was stormy, requiring first sulfamethoxazole and trimethoprim and, later, pentamidine isethionate and ventilatory support to reverse the pneumonic process.

Following this episode of pneumonia, the child's subsequent course was characterized by recurrent episodes of otitis media and thrush, failure to thrive, hepatosplenomegaly, and a slowed acquisition of normal developmental milestones. At the time of her referral to the Pediatric Branch, National Cancer Institute, for antiretroviral therapy, her CD4 lymphocyte count was 0.115 x 103/L and the CD4/CD8 lymphocyte . . . [Full Text PDF of this Article]


Author Affiliations

From the Pediatric Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md.


Footnotes

Reprint requests to the Pediatric Branch, National Cancer Institute, National Institutes of Health, Warren G. Magnuson Clinical Center, Bldg 10, Room 13N240, Bethesda, MD 20892 (Dr Pizzo).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.